{{Rsnum
|rsid=12356193
|Gene=SLC16A9
|Chromosome=10
|position=61413353
|Orientation=plus
|GMAF=0.0955
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 66.4 | 30.1 | 3.5
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 89.8 | 10.2 | 0.0
| ASW | 84.2 | 14.0 | 1.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 78.2 | 19.8 | 2.0
| LWK | 82.7 | 17.3 | 0.0
| MEX | 86.2 | 13.8 | 0.0
| MKK | 91.0 | 9.0 | 0.0
| TSI | 64.7 | 31.4 | 3.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19503597
|Title=Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
|OA=1
}}

{{PMID Auto
|PMID=19890391
|Title=Common polymorphisms influencing serum uric Acid levels contribute to susceptibility to gout, but not to coronary artery disease
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12356193
|overall_frequency_n=16
|overall_frequency_d=128
|overall_frequency=0.125
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23712608
|Title=Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}